Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Industrials · ·
$172.29
▲ $3.29 (+1.9%)
Market data updated: 09/15 11:15 AM
Fundamentals updated: 09/15/2026
News analyzed: 09/15/2026
Market Cap
$20.24B
Day Range
$167.25 - $174.73
52-Week Range
$150.75 - $271.84
Beta
—
Next Earnings
19.10.2026
EFX is a stock from the Industrials sector — Manufacturing, aerospace, defense, and infrastructure — closely tied to capital-investment cycles and economic growth.
-32.8% (1Y)
Strengths: 2/28 factors positiveRisk: High
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🔴 Bearish
Technical Trend
🔴 Bearish
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Operating margin stability
Operating margin is stable or improving over time
Quality
Biggest negative driver
Daily volatility (ATR)
ATR: 4.1% of price
Risk
What to watch next
When today echoes the past.
80/100
Similarity
15
Historical Matches
89/100
Analog Quality
-5.7%
Median 40D Outcome
57/100
Pattern Consistency
🟢 Bullish
47%
+5.4% … +11.6%
🟡 Base
7%
-0.3% … -0.3%
🔴 Bearish
47%
-9.5% … -4.4%
📌 Bottom line: Out of 15 similar historical cases for this stock, 47% (95% CI 25%–70%) saw the stock rise within 20 trading days, with a median gain of -0.3%.
Echo #1 — Momentum Breakout
5 occurrence(s) · 80% historical success
Echo #2 — Oversold Reversal
1 occurrence(s) · 100% historical success
Historical outcome rate is not a probability — it's what happened in this specific historical sample, with a 95% confidence range.
| Horizon | Positive rate (95% CI) | Median | 25th–75th pct | Baseline median |
|---|---|---|---|---|
| 5D | 47% (25%–70%) | +1.0% | -3.5% … +2.0% | +0.3% |
| 10D | 47% (25%–70%) | -0.2% | -3.8% … +4.3% | +0.6% |
| 20D | 47% (25%–70%) | -0.3% | -4.7% … +7.5% | +0.5% |
| 40D | 40% (20%–64%) | -5.7% | -10.8% … +7.9% | +1.5% |
| 60D | 40% (20%–64%) | -0.2% | -8.9% … +6.3% | +0.9% |
Sample size: 15 analogs, each at least 10 trading days apart (no double-counted overlapping events).
What happened after each historical match (20-day return)
| Date | Similarity | Regime | 20D outcome | 60D outcome |
|---|---|---|---|---|
| 2026-03-17 | 80/100 | ✓ Downtrend | -0.3% | -14.8% |
| 2018-02-12 | 76/100 | ✓ Downtrend | +8.2% | -0.5% |
| 2026-04-30 | 73/100 | Downtrend | -4.7% | +7.5% |
| 2025-10-08 | 73/100 | Downtrend | -13.5% | -7.9% |
| 2026-06-15 | 70/100 | Downtrend | +3.9% | +1.8% |
| 2025-08-01 | 70/100 | Downtrend | +2.6% | -4.6% |
| 2025-09-03 | 69/100 | Downtrend | +6.9% | -10.4% |
| 2022-05-02 | 69/100 | Downtrend | -1.4% | +1.0% |
| 2022-09-23 | 68/100 | Downtrend | -13.1% | +9.3% |
| 2025-02-13 | 68/100 | Downtrend | -6.0% | +10.2% |
| 2022-12-19 | 68/100 | Consolidation | +13.7% | +5.1% |
| 2022-02-24 | 68/100 | Downtrend | +9.5% | -9.9% |
| 2022-06-17 | 68/100 | Downtrend | +16.1% | +8.6% |
| 2025-06-25 | 68/100 | Consolidation | -4.7% | -0.2% |
| 2026-03-31 | 67/100 | Downtrend | -4.2% | -12.0% |
Every accepted match is compared to today across 6 domains (price structure, momentum, technical, volatility, volume, relative strength) using z-scored feature distances — no single indicator dominates. Matches within 10 trading days of each other count as one event, not independent evidence. Outcome rates use a Wilson confidence interval (never a raw percentage alone), the mean return is winsorized against extreme outliers, and "Analog Quality" separately captures sample size, data completeness, and regime match — distinct from raw similarity. Relative strength is measured against SPY and against XLI (this stock's sector).
Cross-stock analogs — real other companies, not this stock's own history.
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
43
Today
—
30D
—
90D
—
1Y
🕰️ Signal Timeline
What StockIQ actually saw for this stock, and what happened after each signal — real data, not a forecast.
7d ago · $177.05
Evidence: Narrative Gap moved from 15 to -12 day-over-day
What happened after
Still awaiting outcome
7d ago · $177.05
Evidence: Panic-selling score jumped from 0 to 28 day-over-day
What happened after
Still awaiting outcome
8d ago · $177.05
Evidence: Narrative Gap moved from 15 to -15 day-over-day
What happened after
Still awaiting outcome
8d ago · $177.05
Evidence: Panic-selling score jumped from 0 to 30 day-over-day
What happened after
Still awaiting outcome
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
56
Quality
58
Value
50
Momentum
26
Risk
26
Sentiment
26
Fundamental
54
Institutional
0
Stocks with a similar DNA right now
SCANNING EFX...
Recent media coverage of Equifax has centered on regulatory scrutiny and market volatility. The Consumer Financial Protection Bureau’s updated complaint portal policy now requires consumers to resolve disputes with Equifax, Experian, and TransUnion before escalating to regulators, raising concerns about data accuracy and dispute handling. Additionally, Equifax shares declined alongside FICO and TransUnion after Federal Housing Finance Agency head Bill Pulte criticized credit bureaus for overcharging Americans, pushing for broader adoption of the VantageScore alternative to FICO scores. Investors are reassessing Equifax’s financial health amid these shifts.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Equifax. News trend score: 26. Reason: 8 of the last 20 articles are negative, versus 4 positive.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
27
🎯 Conviction (vs. Emotion)
40
Psychology
33
Fundamentals
54
Technical
26
Valuation
50
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
Extreme momentum, price far above its moving average, and a large premium over fair value.
The price rise has far outpaced the actual improvement in fundamental data.
Price (3M)
+3%
Market Narrative
23
Fundamental Reality
40
Narrative Gap
-17
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The market behavior suggests **herding** as traders align with peers despite EFX’s relative underperformance today. The narrative-reality gap (-10) hints at potential misalignment between market expectations and fundamentals, but herding remains dominant due to peer comparison. Key open question: Will traders continue following peers or reassess fundamentals? The low FOMO/Panic scores imply no extreme sentiment, but herding could persist if peers remain weak. Volatility (1.06x ATR) and neutral RSI (38) suggest cautious, not frantic, behavior.
Updated: 09/09/2026, 04:55 AM
What could change this?
👥 What the crowd believes
"CFPB complaint portal changes put Equifax stock in focus... draws fresh attention to how Equifax handles consumer disputes and data accuracy"
"Fannie and Freddie must approve every lender for VantageScore... credit bureaus are 'overcharging Americans'"
"Financial stocks retreat late afternoon... shares fall after FHFA criticism"
🧠 Market Brain events driving this
📈 7D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Charles Mackay — 100/100
🔴 Weakest match
Benjamin Graham (Enterprising Investor) — 0/100
🗣️ Why do they disagree?
This stock’s starkly divided verdicts reflect a clash between cautious, defensive investors and those who prioritize cyclical or qualitative growth signals. At the top end, **Charles Mackay** and **Samuel Armstrong Nelson** see it as a relatively stable or oversold opportunity, avoiding crowd-driven euphoria or extreme valuations. Meanwhile, **Howard Marks (Market Cycle)** leans bullish on its early-to-mid-cycle positioning, though his broader **Howard Marks** framework flags potential overvaluation. In contrast, **Benjamin Graham** and **Morgan Housel** dismiss it outright—Graham’s strict defensive criteria and Housel’s aversion to volatility make it a non-starter, while **Gerald Loeb** and **Walter Bagehot** warn of liquidity and risk risks. The middle ground, from **Philip Fisher** to **Peter Lynch**, either lacks the growth quality or the value edge to justify holding, illustrating a spectrum where only the most optimistic cyclical or contrarian investors see merit.
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 100
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 90
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟢 73
Looks early-to-mid cycle, not overextended
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 61
Mixed signal on whether growth translates to real profit
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟡 60
Mixed — a good business, but expectations may already be high
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟡 55
Reasonable but not a clear long-term holding
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟡 47
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 42
No clear edge either way
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 36
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🔴 27
Doesn't clear Lynch's growth-at-a-reasonable-price bar
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🔴 15
Risk profile Loeb would flag as a real threat to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🔴 14
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🔴 12
Liquidity position Bagehot would flag as a real risk
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🔴 4
The kind of volatility that tends to shake patient holders out
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🔴 2
Fails most of Graham's defensive criteria
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 0
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
Fact → Principle → Simulation
Based on the last 300 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (1 bullish · 8 bearish · 2 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear uptrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
—
Operating Margin
18.0%
Net Margin
10.9%
EBITDA Margin
30.0%
ROE
14.3%
ROA
5.6%
ROIC
—
EPS
$5.36
Cash
$180.80M
Total Debt
$5.09B
Current Ratio
0.60
Debt/Equity
1.11
אין נתונים היסטוריים זמינים.
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 31.8.2026 | $0.560 |
| 22.5.2026 | $0.560 |
| 21.5.2026 | $0.560 |
| 9.3.2026 | $0.560 |
| 8.3.2026 | $0.560 |
| 24.11.2025 | $0.500 |
| 23.11.2025 | $0.500 |
| 2.9.2025 | $0.500 |
| 1.9.2025 | $0.500 |
| 23.5.2025 | $0.500 |
| 22.5.2025 | $0.500 |
| 21.2.2025 | $0.390 |
How is Fair Value calculated? →
Not enough cash-flow data to calculate a DCF model for this stock.
Book Value per Share
$37.10
Tangible Book Value per Share (Tangible NAV)
-$27.98
Sentiment based on basic keywords (not AI) — 4 positive, 8 neutral, 8 negative out of the last 20 articles.
SeekingAlpha · 14.9.2026
Yahoo · 14.9.2026
SeekingAlpha · 10.9.2026
SeekingAlpha · 9.9.2026
Benzinga · 9.9.2026
MT Newswires · 8.9.2026
ChartMill · 7.9.2026
Yahoo · 5.9.2026
Simply Wall St. · 5.9.2026
Yahoo · 4.9.2026
Barrons.com · 4.9.2026
MT Newswires · 4.9.2026
Barrons.com · 4.9.2026
MT Newswires · 4.9.2026
Yahoo · 4.9.2026
GuruFocus.com · 4.9.2026
ChartMill · 4.9.2026
MT Newswires · 4.9.2026
Yahoo · 4.9.2026
MT Newswires · 4.9.2026
Equifax (EFX) currently has a StockIQ AI score of 43/100, rated "Weak". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
EFX currently scores 43/100 (Weak) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
EFX's technical score is 26/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Operating margin is stable or improving over time; +2.7% over the last 3 months relative to the index.
Based on the real signals StockIQ computed: ATR: 4.1% of price; Current ratio: 0.60; Calmar: -0.09 (3y annualized return -4.3% / max drawdown 50.5%).
Yes — EFX has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 17 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| GAMBLE JOHN W JR | Open Market Sale | 3.9.2026 | 4,500 | -4,500 | $187.96 |
| Larson Barbara A | Grant/Award from Employer | 10.8.2026 | 160 | +160 | $180.07 |
| Larson Barbara A | Grant/Award from Employer | 10.8.2026 | 181 | +181 | $158.72 |
| Larson Barbara A | Grant/Award from Employer | 10.8.2026 | 181 | +181 | $158.72 |
| Larson Barbara A | Grant/Award from Employer | 10.8.2026 | 341 | +160 | $180.07 |
| Begor Mark W | Exercise of Derivative Securities | 24.7.2026 | 37,791 | +37,791 | $112.46 |
| Begor Mark W | Open Market Sale | 24.7.2026 | 1,300 | -1,300 | $174.91 |
| Begor Mark W | Open Market Sale | 24.7.2026 | 6,200 | -6,200 | $171.26 |
| Begor Mark W | Open Market Sale | 24.7.2026 | 21,543 | -21,543 | $172.00 |
| Begor Mark W | Open Market Sale | 24.7.2026 | 600 | -600 | $169.86 |
| Begor Mark W | Exercise of Derivative Securities | 24.7.2026 | 37,791 | -37,791 | — |
| Begor Mark W | Open Market Sale | 24.7.2026 | 2,936 | -2,936 | $173.79 |
| Begor Mark W | Open Market Sale | 24.7.2026 | 600 | -600 | $168.47 |
| Begor Mark W | Open Market Sale | 24.7.2026 | 4,112 | -4,112 | $172.79 |
| Begor Mark W | Open Market Sale | 24.7.2026 | 500 | -500 | $175.85 |
| Begor Mark W | Exercise of Derivative Securities | 24.7.2026 | 309,681 | +37,791 | $112.46 |
| Begor Mark W | Open Market Sale | 24.7.2026 | 309,181 | -500 | $175.85 |
| Begor Mark W | Open Market Sale | 24.7.2026 | 308,581 | -600 | $169.86 |
| Begor Mark W | Open Market Sale | 24.7.2026 | 307,981 | -600 | $168.47 |
| Begor Mark W | Open Market Sale | 24.7.2026 | 306,681 | -1,300 | $174.91 |
| Begor Mark W | Open Market Sale | 24.7.2026 | 303,745 | -2,936 | $173.79 |
| Begor Mark W | Open Market Sale | 24.7.2026 | 299,633 | -4,112 | $172.79 |
| Begor Mark W | Open Market Sale | 24.7.2026 | 293,433 | -6,200 | $171.26 |
| Begor Mark W | Open Market Sale | 24.7.2026 | 271,890 | -21,543 | $172.00 |
| Begor Mark W | Exercise of Derivative Securities | 24.7.2026 | 37,792 | -37,791 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
7,797,437 shares short as of 2026-08-31 · vs. 6,973,116 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
54.7% of trading volume this week was short selling, vs. 57.1% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology